全文获取类型
收费全文 | 5118篇 |
免费 | 365篇 |
国内免费 | 144篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 63篇 |
妇产科学 | 31篇 |
基础医学 | 644篇 |
口腔科学 | 99篇 |
临床医学 | 411篇 |
内科学 | 686篇 |
皮肤病学 | 31篇 |
神经病学 | 450篇 |
特种医学 | 330篇 |
外科学 | 327篇 |
综合类 | 511篇 |
预防医学 | 923篇 |
眼科学 | 71篇 |
药学 | 529篇 |
中国医学 | 191篇 |
肿瘤学 | 297篇 |
出版年
2024年 | 8篇 |
2023年 | 83篇 |
2022年 | 109篇 |
2021年 | 216篇 |
2020年 | 245篇 |
2019年 | 239篇 |
2018年 | 238篇 |
2017年 | 198篇 |
2016年 | 188篇 |
2015年 | 199篇 |
2014年 | 315篇 |
2013年 | 417篇 |
2012年 | 322篇 |
2011年 | 351篇 |
2010年 | 233篇 |
2009年 | 238篇 |
2008年 | 226篇 |
2007年 | 259篇 |
2006年 | 209篇 |
2005年 | 171篇 |
2004年 | 141篇 |
2003年 | 116篇 |
2002年 | 107篇 |
2001年 | 94篇 |
2000年 | 64篇 |
1999年 | 99篇 |
1998年 | 57篇 |
1997年 | 61篇 |
1996年 | 43篇 |
1995年 | 37篇 |
1994年 | 34篇 |
1993年 | 32篇 |
1992年 | 32篇 |
1991年 | 26篇 |
1990年 | 26篇 |
1989年 | 24篇 |
1988年 | 26篇 |
1987年 | 21篇 |
1986年 | 17篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1976年 | 4篇 |
1974年 | 4篇 |
排序方式: 共有5627条查询结果,搜索用时 15 毫秒
1.
2.
中药生产过程质量控制关键技术研究进展 总被引:10,自引:8,他引:2
中医药发展已上升到国家战略层面,在医药行业贯彻实施"中国制造2025"战略的新形势下,中药生产过程质量控制是中药工业需要加快突破的关键领域之一。对中药生产过程质量控制领域在工艺设计、分析检测、过程建模、制造装备等方面的关键共性问题进行解析,综述了中药生产过程质量控制体系中工艺过程理解、生产过程实时分析方法开发、过程控制策略建立3个方面的研究进展;并结合企业研究实践,介绍了质量源于设计(quality by design,Qb D)、过程分析技术(process analytical technology,PAT)、实验设计(design of experiment,DOE)、多变量统计分析等关键技术在上述3个研究方向中的应用进展,分析了实际工业应用的难点问题并对其应用前景进行展望,旨在为中药企业应用和提升生产过程质量控制技术提供参考。 相似文献
3.
目的建立HPLC法测定银杏叶提取物中9种小分子有机酸类成分莽草酸、儿茶素、表儿茶素、没食子酸、原儿茶酸、6-羟基犬尿喹啉酸、对羟基苯甲酸、对羟基肉桂酸、咖啡酸含量的方法,并结合多元统计分析方法比较不同厂家生产的银杏叶提取物间质量差异。方法采用Inertsil ODS-3 C_(18)(250 mm×4.6 mm,5μm)色谱柱;以乙腈-0.4%磷酸水溶液为流动相,梯度洗脱,波长切换测定(220 nm检测莽草酸、儿茶素、表儿茶素,254 nm检测没食子酸、原儿茶酸、6-羟基犬尿喹啉酸、对羟基苯甲酸,310 nm检测对羟基肉桂酸、咖啡酸),柱温40℃。结果不同厂家生产的银杏叶提取物中有机酸总含量有差异,厂家内部样品中各有机酸含量同样存在差异。经聚类分析、主成分分析、相关与回归分析等多元统计方法分析,筛选出儿茶素、没食子酸、原儿茶酸及6-羟基犬尿喹啉酸为体现样品质量差异的特征成分,同时成分间具有内在相关性。结论建立的方法操作简便、重复性好、结果可靠,可用于银杏叶提取物中有机酸类成分的质量评价。筛选出的儿茶素、没食子酸、原儿茶酸及6-羟基犬尿喹啉酸是体现质量差异的特征成分,又是具有内在关联的共性成分,为提升银杏叶提取物整体质量控制能力提供了依据,同时表明银杏叶提取物的提取工艺并不统一,企业内部工艺的稳定性也有待提高。 相似文献
4.
5.
Since the clinical introduction of anti-CD20 monoclonal antibodies into lymphoma treatment, immunologic approaches in lymphoma have made substantial progress. Advances in our understanding of tumor immunology have led to the development of strategies to overcome immunologic barriers responsible for an ineffective immune response. Specifically, therapeutic agents have been developed and tested against molecules that are responsible for T-cell exhaustion. The use of monoclonal antibodies against immune checkpoints in the adaptive immune system, such as programmed cell death-1 and cytotoxic T-lymphocyte-associated protein 4, has changed the landscape of cancer therapy including the treatment of lymphoma. This achievement has recently been accompanied by the development of novel immune checkpoint inhibitors targeting the innate immune system, including the CD47-SIRPα signaling pathway, and this approach has yielded promising results. To overcome impaired antigen presentation, antibody-based cytotoxic strategies, namely antibody-drug conjugates (polatuzumab vedotin and brentuximab vedotin) and bispecific T-cell or NK-cell engagers (blinatumomab, REGN1979, RG6206, and AFM13), have rapidly evolved with promising clinical activity. As additional tools become available for lymphoma treatment, formulation of safe, rational combination strategies to combine them with standard therapy will be of paramount importance. A successful approach to the treatment of lymphoma may require both an optimized anti-tumor immune response as well as effective depletion of malignant lymphoid cells. 相似文献
6.
Kimberly M. Avallone 《The Journal of asthma》2015,52(5):498-504
Objective: Despite its negative effects, smoking is more common among individuals with asthma compared to those without. Anxiety sensitivity (fear of arousal-related sensations) is associated with both smoking and asthma; however, no research, to date, has examined the interplay between these three factors. Thus, the purpose of the current study was to evaluate the mediating role of anxiety sensitivity in the association between asthma diagnosis and smoking status. Methods: The current study was a secondary analysis of data from three existing datasets of non-smokers and smokers with and without asthma (n?=?433; 56.3% female, Mage?=?34.01 years, SD?=?13.9). Participants provided information on their asthma diagnosis status and smoking status and completed self-report measures. Results: As hypothesized, after controlling for gender, race and age, there was a significant indirect effect of asthma diagnosis on smoking status through anxiety sensitivity (95% CI?=?0.07–0.48). Conclusions: These results indicate that the association between asthma diagnosis and smoking status appears to be driven, in part, by anxiety sensitivity and suggest that anxiety sensitivity may serve as an important target for prevention and intervention efforts for smokers with asthma. 相似文献
7.
8.
儿童精神分裂症患者的预后及相关因素分析 总被引:2,自引:1,他引:1
目的探讨儿童精神分裂症的预后及其影响因素。方法收集1987—1997年首次住院的儿童(起病年龄≤14岁)精神分裂症患者(儿童组)124例和同期首次住院的成人(起病年龄25~30岁)精神分裂症患者(成人组)120例,采用社会功能缺陷量表(SDSS)、日常生活能力量表(ADL)、大体评定量表(GAS)及自制调查表,以随访与量表现场测评相结合的方法获得资料,数据采用多因素回归分析。结果(1)儿童组服药依从性(90例,77.6%)好于成人组(73例,64.0%;)χ~2= 5.11,P<0.05);复发率(29.3%)低于成人组(42.1%;χ~2=4.10,P<0.05)。(2)儿童组预后良好者(91例,78.4%)显著多于成人组(65例,57.0%)。(3)儿童组的社会功能[(2.11±1.02)分]和日常生活能力[(18.78±9.17)分]优于成人组[(3.48±1.86)分和(21.82±8.67)分;P<0.01和P<0.05]。(4)经多因素回归分析,影响儿童精神分裂症预后的主要因素有:社会家庭关爱程度,首次住院疗效,起病形式,服药时间和病期(P<0.01)。结论儿童精神分裂症患者总体预后较好;充分的家庭关爱,首次住院疗效好,急性起病,坚持长期治疗和病期较短者的预后更好。 相似文献
9.
One of the first decisions that needs to be taken when planning a birth cohort concerns the size of the study. This in turn will depend on the research questions to be answered and thence whether environmental exposures and outcomes are measured on a continuum or as dichotomous variables. Here we describe ways in which different birth cohorts have addressed this issue and explore the advantages of smaller detailed studies over larger less-detailed studies. 相似文献
10.
This paper presents the use of iterative dynamic programming employing exact penalty functions for minimum energy control problems. We show that exact continuously non-differentiable penalty functions are superior to continuously differentiable penalty functions in terms of satisfying final state constraints. We also demonstrate that the choice of an appropriate penalty function factor depends on the relative size of the time delay with respect to the final time and on the expected value of the energy consumption. A quadratic approximation (QA) of the delayed variables is much better than a linear approximation (LA) of the same for relatively large time delays. The QA improves the rate of convergence and avoids the formation of ‘kinks‘. A more general way of selecting appropriate penalty function factors is given and the results obtained using four illustrative examples of varying complexity corroborate the efficacy of the method. 相似文献